Secukinumab (AIN457), a Novel Monoclonal Antibody Targeting IL-17A Demonstrates Efficacy in Active Rheumatoid Arthritis Patients Despite Stable Methotrexate Treatment: Results of a Phase IIb Study.

L9

  • Genovese, Mark
  • Durez, Patrick
  • Richards, Hanno
  • Hugot, Sophie
  • Thangavelu, Karthinathan
  • Mpofu, Shephard

  • 1Novartis Pharma AG, Basel, Switzerland, 2Stanford University, Palo Alto, CA, 3Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium

Arthritis & Rheumatism 62(12):p 3842, December 2010.
Copyright © 2010, American College of Rheumatology